Effect of Stroke Severity on Efficacy and Safety of Indobufen versus Aspirin in Patients with Moderate to Severe Stroke: Results from the INSURE Randomized Clinical Trial
Journal of Atherosclerosis and Thrombosis · 01.12.2025 · 32 (12) · 1586-1600
DOI: 10.5551/jat.65723 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Atherosclerosis and Thrombosis, erschienen am 01.12.2025. Verfasst von Mengxing Wang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Beijing Tiantan Hospital, Capital Medical University. Hauptthemen laut MEDLINE: Aspirin, Stroke, Platelet Aggregation Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Schlaganfall
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Beijing Tiantan Hospital, Capital Medical University.
- China National Clinical Research Centre for Neurological Diseases.
- Department of Neurology, University of California.
- Stroke Trials Unit, Mental Health & Clinical Neuroscience, University of Nottingham.
- Department of Neurology, Huashan Hospital, State Key Laboratory of Medical Neurobiology, Fudan University.
- Department of Neurology and Stroke Centre, The First Affiliated Hospital of Jinan University.
Zitieren
APA
Wang, M., Pu, S., Jin, A., Johnston, S. C., Bath, P. M., Dong, Q., Xu, A., Yan, H., Meng, X., Yuan, B., Jing, J., Lin, J., Jiang, Y., Xie, X., Pan, Y., & Wang, Y. (2025). Effect of Stroke Severity on Efficacy and Safety of Indobufen versus Aspirin in Patients with Moderate to Severe Stroke: Results from the INSURE Randomized Clinical Trial. Journal of Atherosclerosis and Thrombosis, 32(12), 1586-1600. https://doi.org/10.5551/jat.65723
Vancouver
Wang M, Pu S, Jin A, Johnston SC, Bath PM, Dong Q, et al. Effect of Stroke Severity on Efficacy and Safety of Indobufen versus Aspirin in Patients with Moderate to Severe Stroke: Results from the INSURE Randomized Clinical Trial. Journal of Atherosclerosis and Thrombosis. 2025;32(12):1586-1600. doi:10.5551/jat.65723
BibTeX
@article{Wang2025,
author = {Wang, Mengxing and Pu, Shanyu and Jin, Aoming and Johnston, S Claiborne and Bath, Philip M and Dong, Qiang and Xu, Anding and Yan, Hongyi and Meng, Xia and Yuan, Baoshi and Jing, Jing and Lin, Jinxi and Jiang, Yong and Xie, Xuewei and Pan, Yuesong and Wang, Yongjun},
title = {Effect of Stroke Severity on Efficacy and Safety of Indobufen versus Aspirin in Patients with Moderate to Severe Stroke: Results from the INSURE Randomized Clinical Trial},
journal = {Journal of Atherosclerosis and Thrombosis},
year = {2025},
volume = {32},
number = {12},
pages = {1586--1600},
doi = {10.5551/jat.65723}
}
EUVIMED